The NHS’s puberty-blockers trial is a danger to children

The Cass Review , a comprehensive four-year investigation into NHS England’s gender-identity services, found that there was no evidence to support the use of the drugs in children.

Blockers don’t permanently stop gender distress, they lock it in, setting children on a medicalised path to sterilisation.

The drugs may permanently disrupt the brain maturation of adolescents, potentially rewiring neural circuits that cannot be reversed'.

The NHS recognised that puberty blockers were harmful when it ended their routine prescription in March 2024 .

Instead of following the lead of Sweden , Finland , and Norway , which have pulled back on these treatments due to serious safety concerns, the UK is now ploughing ahead with bringing them back, eyes squeezed shut, fingers jammed in ears.